Navigation Links
Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macoven's Discontinuance of Certain Products
Date:7/9/2013

BOCA RATON, Fla., July 9, 2013 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that Nestle Health Science-Pamlab and Merck & Cie have dismissed their patent litigation against Macoven Pharmaceuticals, LLC., and Breckenridge has dismissed its Lanham Act litigation against Macoven.   In return, Macoven has agreed to immediately and permanently cease all manufacturing, use, sale, offers for sale, importation, distribution, advertising, promotion, marketing its generic, unlicensed L-methylfolate calcium salt products.   Macoven's discontinued products include:  VitaCirc-B, Alz-NAC, L Methylfolate PNV DHA, L-Methylfolate Calcium 7.5, and L-Methylfolate Calcium 15.

Merck & Cie is the exclusive manufacturer and supplier of the ingredient Metafolin® (L-methylfolate calcium), and is the owner of multiple U.S. patents covering Metafolin®.   Nestle Health Science-Pamlab markets the only branded medical foods in the United States which contain Metafolin®.  Since 2007, Breckenridge has served as the exclusive authorized-generic supplier of Nestlé Health Science-Pamlab brands, from folic acid products to Metafolin®-containing medical foods.  

About Breckenridge Pharmaceutical, Inc.
Breckenridge is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products and Medical Foods in many therapeutic categories. The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide. The company markets over 60 products in a variety of dosage forms including: Tablets, Capsules, Soft Gel Capsules, Liquids, and Powders.

 


'/>"/>
SOURCE Breckenridge Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
2. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
3. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
4. BiOptix announces low cost Surface Plasmon Resonance Services for Colorado-based researchers
5. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
6. Blue Sky BioServices Expands its Executive Team - Announces Appointment of Ted Marple as President and CEO
7. Concord Medical Announces Launch of Mobile Health Application
8. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
9. Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
10. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
11. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017   The Accreditation Council for Medical ... in the pharmaceutical industry has appointed Dr. ... newly formed scientific advisory board. Dr. Chin will ... first ever medical affairs think tank within the ... the ACMA, please visit  www.medicalaffairsspecialist.org .  Connect ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 ... market of deep learning solutions within the healthcare domain. Primarily driven ... a novel solution to generate relevant insights from medical data. ...
(Date:3/24/2017)... -- GenomeDx Biosciences today announced that six abstracts featuring Decipher ... Classifier tests will be presented at the 32 nd ... March 24 to 28, 2017 in London, ... Europe,s largest urological event showcasing the ... The abstract titled "Muscle invasive bladder cancer: ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... ... spark a conversation on the current obstacles facing infection prevention and offer strategies ... deaths caused by these infections. , The print component of “Fighting Infection” ...
(Date:3/24/2017)... Dallas, Texas (PRWEB) , ... March 24, 2017 , ... ... Budget Office score is invalid because it does not obey the rules Congress has ... million full-time equivalent jobs, which the GOP reform would restore. Yet, it estimates a ...
(Date:3/24/2017)... Sedona, Arizona (PRWEB) , ... March 24, 2017 ... ... Shamangelic Healing Center, Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, ... Jorge Luis Delgado, June 9--24, 2017. This sacred and spiritual journey during ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She ... Record, The majority of cases litigated under ERISA involve claims for long-term disability ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
Breaking Medicine News(10 mins):